Novel combinations for treatment of recurrent cervical cancer

Video Transcription

Video Summary

This video is a discussion between Dr. Brad Monk, Director of the GOG Foundation, and Dr. Wendell Mellon, Associate Director of Clinical Trials at Levine Cancer Institute. The focus of the discussion is on the advancements in the treatment of recurrent metastatic cervical cancer. Dr. Monk discusses various treatment options, including combination therapies and targeted therapies. He highlights the positive outcomes of recent clinical trials and emphasizes the importance of early detection and prevention through vaccination and screening. Dr. Mellon raises questions about the sequencing of treatments and the potential impact of radiation therapy on immune response. Dr. Monk also mentions ongoing and upcoming trials, including those investigating tissue factor ADCs and combinations with checkpoint inhibitors. He concludes by mentioning the upcoming IGCS meeting in Seoul and encourages viewers to attend. The transcript does not explicitly mention any credits granted.

Keywords

recurrent metastatic cervical cancer

treatment options

clinical trials

early detection

radiation therapy

immune response

IGCS meeting